Laparoscopic Sleeve Gastrectomy Short Term Follow up
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Assessment of excess weight loss
Study Overview
Brief Summary
Laparoscopic Sleeve Gastrectomy (LSG), Also known as longitudinal or vertical gastrectomy.
LSG was initially considered a first-stage operation in high-risk patients before bilio-pancreatic diversion or Roux-en-Y gastric bypass surgery. However, LSG was subsequently found to be effective as a single procedure for treatment of morbid obesity.LSG functions mainly as a restrictive procedure in which about 75 % of the stomach is removed leaving a narrow gastric tube or sleeve. So, it limits the amount of food that can be eaten at one time via inducing early satiety after eating a small amount of food due to early distension of the fashioned gastric sleeve giving a sense of satiety, consequently losing excess body weight by time.Sleeve gastrectomy may also cause a decrease in appetite by reducing the amount of Ghrelin (hunger hormone) produced by the stomach.
Detailed Description
All patients,males and females with age (20-50 years old) with morbid obesity (BMI ≥ 40 kg/m2 or > 35 kg/m2 associated with co-morbidity) randomly admitted to Assiut University Hospital-General Surgery Department.
Pre-operative: Assessment of; BMI (Body Mass Index), Fasting Blood Glucose level (FBG), Associated Co-morbidities (as hypertensions & sleep apnea).
Operative (During Operation):
All patients undergo LSG by single team work with intra-operative oesophageal bougie 36 french with use of laparoscopic gastro-intestinal anastomosis(GIA) stapler.
Post-operative:
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •All patients,males and females with age (20-50 years old) with morbid obesity (BMI ≥ 40 kg/m2 or > 35 kg/m2 associated with co-morbidity), and are fit for laparoscopic surgery.
Exclusion Criteria
- •Patients having severe co-morbidity who are not fit for surgery or general anaesthesia.
- •Patients with age below 20 years or above 50 years.
Arms & Interventions
Laparoscopic Sleeve Gastrectomy
Laparoscopic sleeve gastrectomy for patients with morbid obesity using the gastro-intestinal anastomosis stapler.
Intervention: Laparoscopic Sleeve Gastrectomy (Procedure)
Outcomes
Primary Outcomes
Assessment of excess weight loss
Time Frame: First six months after surgery
Assessment of excess weight loss six months after the operation.
Secondary Outcomes
No secondary outcomes reported
Investigators
Mohamed Gamal Thabet
Principal investigator
Assiut University